Tag: Minimal Residual Disease Testing Market

According to a recent report, the global minimal residual disease testing market is poised for remarkable growth, projected to reach USD 2.3 billion by 2027, with a robust compound annual growth rate of 14.0%. This surge is fueled by various factors including the increasing prevalence …

Minimal residual disease (MRD) testing is a diagnostic method used to detect the presence of cancer cells in patients who have completed treatment for cancer. It is an essential tool for monitoring cancer patients’ response to treatment and predicting the likelihood of disease recurrence. The …